Jane Street Group, LLC Global Blood Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $5.38 Million - $11.3 Million	-165,937 Reduced 72.19%	63,922 $4.35 Million
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $5.38 Million - $11.3 Million	-165,937 Reduced 72.19%	63,922 $4.35 Million
Q2 2022 Aug 16, 2022	BUY	$22.3 - $37.39 $411,814 - $690,481	18,467 Added 8.74%	229,859 $7.34 Million
Q1 2022 May 17, 2022	BUY	$25.68 - $35.59 $2.49 Million - $3.45 Million	97,073 Added 84.91%	211,392 $7.32 Million
Q4 2021 Feb 15, 2022	BUY	$24.9 - $40.26 $1.33 Million - $2.16 Million	53,592 Added 88.25%	114,319 $3.35 Million
Q3 2021 Nov 16, 2021	BUY	$25.48 - $37.34 $425,847 - $624,063	16,713 Added 37.97%	60,727 $1.55 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $362,286 - $484,610	11,161 Added 33.97%	44,014 $1.54 Million
Q1 2021 May 18, 2021	SELL	$38.94 - $50.85 $2.48 Million - $3.23 Million	-63,578 Reduced 65.93%	32,853 $1.34 Million
Q4 2020 Feb 17, 2021	BUY	$37.65 - $63.77 $2.42 Million - $4.1 Million	64,235 Added 199.51%	96,431 $4.18 Million
Q3 2020 Nov 17, 2020	SELL	$52.76 - $74.49 $3.78 Million - $5.34 Million	-71,646 Reduced 69.0%	32,196 $1.78 Million
Q2 2020 Aug 17, 2020	BUY	$48.73 - $81.82 $4.72 Million - $7.92 Million	96,837 Added 1382.4%	103,842 $6.56 Million
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $327,074 - $585,872	-7,157 Reduced 50.54%	7,005 $557,000
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $565,968 - $722,716	-12,480 Reduced 46.84%	14,162 $687,000
Q2 2019 Aug 15, 2019	BUY	$52.6 - $63.29 $771,799 - $928,654	14,673 Added 122.59%	26,642 $1.4 Million
Q1 2019 May 16, 2019	BUY	$39.99 - $53.48 $188,392 - $251,944	4,711 Added 64.91%	11,969 $634,000
Q4 2018 Feb 15, 2019	BUY	$31.54 - $46.67 $9,525 - $14,094	302 Added 4.34%	7,258 $298,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $753,160 - $1.01 Million	-19,820 Reduced 74.02%	6,956 $264,000
Q2 2018 Aug 15, 2018	BUY	$38.7 - $50.15 $354,259 - $459,073	9,154 Added 51.95%	26,776 $1.21 Million
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $282,427 - $469,998	7,132 Added 67.99%	17,622 $851,000
Q4 2017 Feb 15, 2018	BUY	$29.7 - $45.7 $120,077 - $184,765	4,043 Added 62.71%	10,490 $413,000
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $161,819 - $200,179	6,447	6,447 $200,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account